USPTO serial 73744164
BEBULIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 7, 1989
- Examiner
- MANDIR, FREDERICK
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BEBULIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
A1221 WIEN, AT
IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
WIEN, AT
Other trademarks owned by IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
WIEN, AT
Other trademarks owned by IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
DEERFIELD, IL
IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
WIEN, AT
Other trademarks owned by IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey Nichols
Jeffrey Nichols Baxter International Inc.One Baxter ParkwayTrademark Dept.Deerfield, IL 60015Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICALS, NAMELY COAGULATION FACTOR CONCENTRATE FOR PROPHYLAXIS AND TREATMENT OF PATIENTS WITH BLEEDING DISORDERS | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IMMUNO ATKIENGESELLSCHAFT
- Other trademarks owned by IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
- Other trademarks owned by IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
- Other trademarks owned by BAXTER INTERNATIONAL INC.
- Other trademarks owned by IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE
- Other trademarks in Class 005
- Similar marks named BEBULIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2009 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 29, 2008 | CFIT | CASE FILE IN TICRS | — |
| Dec 4, 2007 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 4, 2007 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 5, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 24, 1995 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 31, 1995 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Mar 7, 1989 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 1988 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 19, 1988 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 11, 1988 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 28, 1988 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 23, 1988 | DOCK | ASSIGNED TO EXAMINER | — |